ISFTD 2024 Conference Highlights
Dementia Researcher Vodcast
09/29/24
•49m
About
Comments
Featured In
In this podcast we bring you highlights from the International Society for Frontotemporal Dementias (ISFD) Conference, which was held in Amsterdam from the 19th to 22nd September 2024.
Dr Anna Volkmer talks with Dr Martyna Matuszyk from Alzheimer’s Society and Dr Aitana Sogorb Esteve from University College London discussing their highlights and recapping on the event and what they’re taking away from this year’s talks.
- Advancements in FTD Research: Key research on the genetic and molecular mechanisms of frontotemporal dementia, particularly focusing on biomarkers for early diagnosis.
- Novel Therapeutic Approaches: Promising developments in treatments targeting FTD-specific pathology, with potential to improve patient outcomes.
- Challenges in Translating Research to Practice: The complexity of moving lab discoveries into clinical applications, and the need for more streamlined processes.
- Importance of Collaboration: Emphasis on interdisciplinary cooperation to address the multifaceted nature of dementia research.
- Breakthroughs in Neuroimaging: Advances in neuroimaging techniques that could enhance understanding of disease progression and improve diagnostic accuracy.
- Public and Patient Involvement: The vital role of involving patients and the public in shaping research agendas, ensuring that studies address real-world needs.
- Effective Science Communication: The need to translate complex scientific information into accessible language for both the public and other stakeholders.
- Annual ISFTD Conference: Excitement around the announcement that the conference will be held annually starting in 2026, fostering more frequent collaboration and knowledge sharing.
The International Society for Frontotemporal Dementias is a non-profit scientific society focused on frontotemporal dementias. Members include the leaders in FTD research around the world, and the society is associated with a large, international biannual meeting (soon to be annual) presenting the latest findings.
For more information visit: www.isftd.org
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
https://dementia-researcher.captivate.fm/support
Follow us on social media:
- https://www.instagram.com/dementia_researcher/
- https://www.facebook.com/Dementia.Researcher/
- https://www.twitter.com/demrescommunity
- https://www.linkedin.com/company/dementia-researcher
- https://bsky.app/profile/dementiaresearcher.bsky.social
Download and Register with our Community App:
https://www.onelink.to/dementiaresearcher
We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.
The views and opinions expressed by guests...
Previous Episode
The Epigenetic Equation
September 15, 2024
•61m
In this episode of the Dementia Researcher Podcast, guest host Dr Fiona McLean is joined by Dr Josh Harvey (University of Exeter), Dr Sarah Marzi (King’s College London - UK Dementia Research institute), Dr Alexi Nott (Imperial College London - UK Dementia Research institute), and Dr Sam Washer (Wellcome Trust Sanger Institute) to discuss the role of epigenetics in Alzheimer’s and dementia research.
The episode offers a broad exploration of epigenetics in neurodegenerative diseases, highlighting how gene regulation beyond DNA sequences is advancing our understanding of Alzheimer’s and related conditions. It covers the impact of environmental and lifestyle factors on disease development, as well as emerging research techniques and technologies that could inform future diagnostic and therapeutic approaches.
Key Topics:
- The fundamentals of epigenetics and its distinction from traditional genetics.
- How epigenetic research is shaping our understanding of Alzheimer's disease.
- The role of environmental factors in influencing epigenetic changes.
- New technologies and their application in epigenetic studies.
- The potential for epigenetics in developing future diagnostics and therapies for neurodegenerative diseases.
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
https://dementia-researcher.captivate.fm/support
Follow us on social media:
- https://www.instagram.com/dementia_researcher/
- https://www.facebook.com/Dementia.Researcher/
- https://www.twitter.com/demrescommunity
- https://www.linkedin.com/company/dementia-researcher
- https://bsky.app/profile/dementiaresearcher.bsky.social
Download and Register with our Community App:
https://www.onelink.to/dementiaresearcher
We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.
The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.
Subscribe to our sister show 'Dementia Researcher The Blogs':
Next Episode
Alzheimer Europe 2024 Conference Highlights - Part One
October 10, 2024
•30m
Last week Dementia Researcher attended the 34th Alzheimer Europe Conference in Geneva, Switzerland. In this podcast Dr Megan Rose Readman and her guests bring you highlights from event, sharing news and their best bits from the hundreds of posters and talks delivered.
Dr Megan Rose Readman talks with Dr Fiona Carragher from Alzheimer’s Society and Dr Andy Northcott from the Geller Institute of Ageing and Memory, University of West London and Dr Sébastien Libert from Alzheimer Europe.
This year’s Alzheimer Europe Conference, themed 'New Horizons – Innovating for Dementia,' brought together a diverse group of participants, including people living with dementia, carers, volunteers, Alzheimer association staff, policymakers, health and social care professionals, researchers, and academics. It remains a unique platform where the latest advances in fundamental science, care, policy, and public engagement are shared and discussed.
Here are a few highlights of note:
- Progress in Alzheimer's treatment: New drugs that slow disease progression mark a significant breakthrough in 2024.
- Progress in Care and Support: There was a strong focus on improving care and support with lots of new ideas and improvements in how to provide the best care, some of which involves technological advancements are playing a growing role in improving care and enhancing quality of life and understanding of disease and prevention.
- Challenges in healthcare: The need for systemic changes to prepare for new treatments is a pressing issue.
- Powerful stories: The conference featured multiple testimonies from people living with dementi and carers that resonated with attendees.
- Public and patient involvement: Engaging those with lived experience in research and policy is crucial.
- Promising future for research: Early career researchers are contributing significantly, offering hope for the future of dementia research.
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
https://dementia-researcher.captivate.fm/support
Follow us on social media:
- https://www.instagram.com/dementia_researcher/
- https://www.facebook.com/Dementia.Researcher/
- https://www.twitter.com/demrescommunity
- https://www.linkedin.com/company/dementia-researcher
- https://bsky.app/profile/dementiaresearcher.bsky.social
Download and Register with our Community App:
https://www.onelink.to/dementiaresearcher
We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.
The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.
Subscribe to our sister show 'Dementia Researcher The Blogs':
If you like this episode you’ll love
Promoted